The base-case results assuming 2 retreatments demonstrated better cost-effectiveness than the C2H results (no retreatment), which represent the cost-effectiveness analysis of semaglutide 2.4 mg in Japan (C2H non-T2D, 13 095 027/QALY
Clear, accessible communication about these programs in public-facing carrier materials
Over the course of a 2-day workshop in Bethesda, Maryland, this week, RECOVER representatives detailed plans to launch clinical trials for several interventions
When dining out or travelling, exercise additional caution
The study authors themselves have called for: Larger retrospective, multicenter population-based studies Prospectively designed randomized clinical trials Postmarket analysis of all GLP-1 receptor agonists One challenge in conducting these studies is the lack of a specific diagnostic code for NAION, which may complicate large-scale data collection
Optimal dosing and administration strategies ensure safe and effective results